What's new? Log in Free sign up

Filing search / Context Therapeutics Inc. / "Investigation"

Search information

Context Therapeutics Inc.

Companies

"Investigation"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

31 results

Newest first Best match first

CNTX Context Therapeutics Inc.

Shelf registration

be incurred by it in compliance with such request or direction. (g) The Trustee shall not be bound to make any investigation into the facts … , other evidence of indebtedness or other paper or document, but the Trustee, in its discretion, may make such further inquiry or investigation

6 Nov 24

4:42pm

CNTX Context Therapeutics Inc.

Shelf registration

thereof or other investigation. We have assumed, without investigation, the following: (a) the genuineness of signatures, including electronic signatures

6 Nov 24

4:42pm

CNTX Context Therapeutics Inc.

Context to obtain exclusive development and commercialization rights to BA3362

, to the extent applicable, any comparable filing(s) outside the U.S. for the clinical investigation of any product in any other country or group of countries … hereunder is or becomes a Debarred Entity or if any action, claim, investigation, or other legal or administrative proceeding is pending or, to the best

CNTX Context Therapeutics Inc.

Quarterly report

investigation by the Board or the Compensation Committee, or (ii) any negotiations between the Board and Executive regarding any actual or alleged act … a claim or assisting with an investigation directly with a self-regulatory authority or a government agency or entity, including the U.S. Equal

7 Aug 24

4:07pm

CNTX Context Therapeutics Inc.

Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

by this Agreement. 4.4 Litigation. To the best of Buyer’s knowledge, there is no litigation, suit, action, arbitration, inquiry, investigation … SUCH PURCHASED ASSETS. 5.4 Litigation. To the best of Seller’s knowledge, there is no claim, action, arbitration, inquiry, investigation, suit

kmy4bjfyzw73pig9

Shelf registration

24 May 24

7:31am

Context Therapeutics Announces $100 Million Private Placement

Context Therapeutics Announces $100 Million Private Placement

Shelf registration

Shelf registration

Quarterly report

9 Nov 22

4:06pm

Quarterly report

11 Aug 22

4:03pm

Quarterly report

11 May 22

4:18pm

9amuhp1e2lo86gj9

Context Therapeutics® Strengthens Research & Development Team

2bqd58we3acthxp

IPO registration

10 Dec 21

4:46pm

ite731upd2ci1msad4y

Quarterly report

Quarterly report

po40nqo5h4 g4og

Context Therapeutics® Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Legal Officer

Departure of Directors or Certain Officers

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.